Clinical Trials Directory

Trials / Unknown

UnknownNCT06043895

EpiFaith CV for Central Venous Catheterization

The Overall Surgical Time Comparison Between EpiFaith® CV and Conventional Syringe in Central Venous Catheterization

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
National Taiwan University Hospital · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

EpiFaith CV provides automatic aspiration and detection of arterial pressure as an alternative to manometry in central venous catheterization. The aim of the study is to evaluate if it may reduce operation time compared with conventional syringe.

Detailed description

Central venous catheterization (CVC) is crucial in modern perioperative and intensive care. Keeping constant and stable negative pressure while advancing the needle had been issue for beginners. Recently, EpiFaith CV provides a new solution for CVC, which facilitates syringe control and precision during assessing vessels. It provides steady aspiration and detection of arterial pressure as an alternative to manometry without the need to disconnect nor more connections. The aim of the study is to evaluate if it may reduce operation time compared with conventional syringe.

Conditions

Interventions

TypeNameDescription
DEVICEEpiFaith CVThe conducting physician will localize the central vein using EpiFaith CV and assess if there is arterial puncture.
DEVICEConventionalThe conducting physician will localize the central vein using Raulerson syringe and assess if there is arterial puncture.

Timeline

Start date
2023-09-01
Primary completion
2024-06-01
Completion
2024-12-01
First posted
2023-09-21
Last updated
2023-09-22

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT06043895. Inclusion in this directory is not an endorsement.